{"id":8116,"date":"2020-04-06T13:48:12","date_gmt":"2020-04-06T17:48:12","guid":{"rendered":"http:\/\/localhost:10028\/uncategorized\/fda-demands-zantac-recall\/"},"modified":"2020-04-06T13:48:12","modified_gmt":"2020-04-06T17:48:12","slug":"fda-talepleri-zantac-geri-cagirma","status":"publish","type":"post","link":"https:\/\/napolilaw.lemonadestand.org\/tr\/article\/fda-talepleri-zantac-geri-cagirma\/","title":{"rendered":"FDA, Zantac'\u0131n Geri \u00c7a\u011f\u0131r\u0131lmas\u0131n\u0131 Talep Etti"},"content":{"rendered":"

Son kan\u0131tlar, pop\u00fcler mide ek\u015fimesi ilac\u0131n\u0131 artan kanser riskiyle ili\u015fkilendirir, bu nedenle FDA, Zantac'\u0131n geri \u00e7a\u011fr\u0131lmas\u0131n\u0131 talep eder. Ajans t\u00fcm ranitidinin ma\u011faza raflar\u0131ndan kald\u0131r\u0131lmas\u0131n\u0131 istiyor hemen etkili<\/a>.<\/p>\n

\u015eu anda G\u0131da ve \u0130la\u00e7 \u0130daresi, Sanofi'ye ve di\u011fer ranitidin \u00fcreticilerine \u00fcr\u00fcn yapmay\u0131 ve sevk\u0131yat\u0131 durdurmalar\u0131n\u0131 isteyen mektuplar g\u00f6nderiyor.<\/p>\n

Ek olarak, FDA t\u00fcketicilere re\u00e7etesiz Zantac almay\u0131 derhal b\u0131rakmalar\u0131n\u0131 ve kullan\u0131lmayan haplar\u0131 imha etmelerini tavsiye ediyor.<\/p>\n

Ajans\u0131n web sitesi \u015funlar\u0131 i\u00e7erir: g\u00fcvenli imha talimatlar\u0131<\/a> koronavir\u00fcs salg\u0131n\u0131 s\u0131ras\u0131nda.<\/p>\n

Zantac re\u00e7etesi alan ki\u015filer, talimat i\u00e7in doktorlar\u0131yla ileti\u015fime ge\u00e7melidir.<\/p>\n

\u015eirket yapt\u0131\u011f\u0131 a\u00e7\u0131klamada, "\u00f6n test sonu\u00e7lar\u0131nda baz\u0131 tutars\u0131zl\u0131klar" oldu\u011funu kabul etti.<\/p>\n

Tehlikeli \u0130la\u00e7lar Neden Piyasaya S\u00fcr\u00fcl\u00fcyor?<\/b><\/h2>\n

Milletvekilleri, y\u00fcz y\u0131ldan biraz daha uzun bir s\u00fcre \u00f6nce G\u0131da ve \u0130la\u00e7 \u0130daresi'ni yaratt\u0131.<\/p>\n

O zamanlar herhangi birine bir \u015fey satmak yasald\u0131.<\/p>\n

"Y\u0131lan ya\u011f\u0131" seyyar sat\u0131c\u0131lar neredeyse her yerdeydi. Ayr\u0131ca Bayer, eroini paketledi ve \u00e7ocuklarda \u00f6ks\u00fcr\u00fck kesici olarak satt\u0131.<\/p>\n

Bir s\u00fcre i\u00e7in FDA, Mesleki G\u00fcvenlik ve Sa\u011fl\u0131k \u0130daresi ve baz\u0131 benzer kurumlar gibi etkili ve tamamen ba\u011f\u0131ms\u0131z bir g\u00f6zlemciydi.<\/p>\n

\u015eimdi i\u015fler farkl\u0131. Kullan\u0131c\u0131 \u00fccretleri hesab\u0131 \u00fc\u00e7te birden fazla<\/a> FDA'n\u0131n b\u00fct\u00e7esinden.<\/p>\n

Ba\u015fka bir deyi\u015fle, FDA'n\u0131n d\u00fczenledi\u011fi ila\u00e7 \u015firketleri, ajans\u0131n finansal a\u00e7\u0131dan \u00e7al\u0131\u015fmas\u0131n\u0131 sa\u011flar.<\/p>\n

Dolay\u0131s\u0131yla bu b\u00fcrokratlar ila\u00e7 geli\u015ftirme s\u00fcrecinde \u00e7ok fazla soru sormuyorlar.<\/p>\n

Ne kadar \u00e7ok ila\u00e7 piyasaya s\u00fcr\u00fcl\u00fcrse, ila\u00e7 \u015firketleri o kadar \u00e7ok para kazan\u0131r ve FDA o kadar \u00e7ok para al\u0131r.<\/p>\n

Ek olarak, ayn\u0131 nedenlerle, FDA yaln\u0131zca a\u015f\u0131r\u0131 durumlarda \u00fcr\u00fcn geri \u00e7a\u011f\u0131rma emri verir. Yani, ajans Zantac'\u0131 geri \u00e7a\u011f\u0131rd\u0131ysa veya geri \u00e7a\u011f\u0131rma emri verdiyse, bunun nedeni a\u00e7\u0131k\u00e7a riskin son derece y\u00fcksek olmas\u0131d\u0131r.<\/p>\n

Ne yaz\u0131k ki Zantac'\u0131n geri \u00e7a\u011fr\u0131lmas\u0131, Zantac'\u0131 al\u0131p tehlikeli bir kimyasala maruz kalan milyonlarca insan i\u00e7in \u00e7ok ge\u00e7 geldi.<\/p>\n

Zantac ve NDMA<\/b><\/h2>\n

N-Nitrosodimetilamin genellikle belirli \u00fcretim ve safla\u015ft\u0131rma i\u015flemlerinin bir yan \u00fcr\u00fcn\u00fcd\u00fcr.<\/p>\n

Bu nedenle, NDMA, i\u015flenmi\u015f suda ve kurutulmu\u015f ette olduk\u00e7a yayg\u0131nd\u0131r. Bu kimyasal bilinen bir kanserojendir. Laboratuvar hayvanlar\u0131nda t\u00fcm\u00f6rler \u00fcretti.<\/p>\n

Litre ba\u015f\u0131na yakla\u015f\u0131k dokuz nanogram gibi son derece d\u00fc\u015f\u00fck seviyelerde NDMA zararl\u0131 de\u011fildir. Zantac'taki seviyeler yakla\u015f\u0131k on kere<\/a> o kadar y\u00fcksek<\/p>\n

Geli\u015ftirme s\u0131ras\u0131nda FDA, ilac\u0131n kendisinde ve ayr\u0131ca ilac\u0131n mide asidine maruz kalmas\u0131ndan sonra NDMA seviyeleri talep etti.<\/p>\n

Ancak, kullan\u0131lmayan Zantac genellikle haftalarca veya aylarca ecza dolab\u0131nda kalmas\u0131na ve Zantac'\u0131n etiketi kullan\u0131c\u0131lara bu \u015fekilde saklamalar\u0131 talimat\u0131n\u0131 vermesine ra\u011fmen, d\u00fczenleyiciler uzun s\u00fcreli oda s\u0131cakl\u0131\u011f\u0131nda saklaman\u0131n etkilerini test etmedi.<\/p>\n

Anla\u015f\u0131ld\u0131\u011f\u0131 \u00fczere, uzun s\u00fcreli oda s\u0131cakl\u0131\u011f\u0131nda saklama, ilac\u0131n kimyasal yap\u0131s\u0131n\u0131 de\u011fi\u015ftirerek NDMA seviyelerinin endi\u015fe verici derecede y\u00fcksek seviyelere \u00e7\u0131kmas\u0131na neden oldu.<\/p>\n

Zanta'y\u0131 geri \u00e7a\u011f\u0131rmak i\u00e7in yap\u0131lan bu hareketten \u00f6nce, FDA Zantac'\u0131 1983'te onaylad\u0131. 2007'den bu yana, y\u0131lda yakla\u015f\u0131k on yedi milyon re\u00e7eteyle s\u00fcrekli olarak piyasadaki en \u00e7ok re\u00e7ete edilen ila\u00e7lardan biri oldu.<\/p>\n

D\u00fczenleyiciler, ranitidin\/NDMA ba\u011flant\u0131s\u0131n\u0131 ilk olarak 2019'da incelediler, ancak \u015fimdiye kadar bir nedeni tam olarak belirleyemediler. \u0130lgin\u00e7 bir \u015fekilde, famotidin (Pepcid) ve omeprazol (Prilosec) gibi baz\u0131 benzer ila\u00e7lar, y\u00fcksek NDMA seviyelerine sahip de\u011fildir.<\/p>\n

Tehlikeli \u0130la\u00e7lar Sorumlulu\u011fu<\/b><\/h2>\n

Araba kazalar\u0131 ve t\u0131bbi yanl\u0131\u015f te\u015fhis gibi \u00e7o\u011fu yaralanma iddias\u0131, ihmal veya bak\u0131m eksikli\u011fini i\u00e7erir. Daval\u0131 bir \u015fekilde ihmalkarsa, ma\u011fdurlar tazminat alma hakk\u0131na sahiptir.<\/p>\n

Ancak tehlikeli uyu\u015fturucu iddialar\u0131 farkl\u0131d\u0131r, \u00e7\u00fcnk\u00fc b\u00fcy\u00fck \u00f6l\u00e7\u00fcde \u00e7ok say\u0131da insan\u0131 etkilerler ve potansiyel etkileri \u00e7ok ciddidir.<\/p>\n

\u00dcreticiler kesinlikle sorumlu<\/a> tehlikeli \u00fcr\u00fcnlerinin neden oldu\u011fu hastal\u0131k veya yaralanmalar i\u00e7in.<\/p>\n

\u0130hmal veya ihmal, yaln\u0131zca h\u00fckmedilen tazminat miktar\u0131 a\u00e7\u0131s\u0131ndan ge\u00e7erlidir.<\/p>\n

A\u015fa\u011f\u0131da bununla ilgili daha fazla bilgi var. Bunun yerine, ma\u011fdurlar yaln\u0131zca kan\u0131tlar\u0131n \u00fcst\u00fcnl\u00fc\u011f\u00fcyle (muhtemelen b\u00fcy\u00fck olas\u0131l\u0131kla) nedensel bir ba\u011flant\u0131 kurmal\u0131d\u0131r. Bu, New York'taki en d\u00fc\u015f\u00fck kan\u0131t standard\u0131.<\/p>\n

Yasal unsurlar olduk\u00e7a basit ve ispat y\u00fck\u00fc d\u00fc\u015f\u00fck olmas\u0131na ra\u011fmen, bu davalar\u0131 mahkemede ispatlamak genellikle olduk\u00e7a zordur.<\/p>\n

Sanofi ve di\u011fer b\u00fcy\u00fck ila\u00e7 \u00fcreticilerinin neredeyse s\u0131n\u0131rs\u0131z kaynaklar\u0131 var.<\/p>\n

Dolay\u0131s\u0131yla bu \u015firketler, ilac\u0131n anne s\u00fct\u00fc kadar g\u00fcvenli oldu\u011funa tan\u0131kl\u0131k edecek bilirki\u015fileri kolayl\u0131kla bulabiliyor.<\/p>\n

Uzman tan\u0131k de\u011ferlendirmesi s\u00f6z konusu oldu\u011funda, New York di\u011fer baz\u0131 eyaletlerden daha rahat bir standart kullan\u0131yor.<\/p>\n

Bu nedenle, New York'taki bir ki\u015fisel yaralanma avukat\u0131n\u0131n, ilac\u0131n kanserle ba\u011flant\u0131s\u0131 veya her neyse hakk\u0131nda tan\u0131kl\u0131k edecek daha geni\u015f bir uzman se\u00e7ene\u011fi var.<\/p>\n

Bir avukat, yaln\u0131zca alan\u0131nda bilgili de\u011fil, ayn\u0131 zamanda mahkemede \u00e7ok ikna edici uzmanlarla ortak olabilir.<\/p>\n

Tehlikeli bir uyu\u015fturucu vakas\u0131ndaki tazminat genellikle t\u0131bbi faturalar gibi ekonomik kay\u0131plar ve a\u011fr\u0131 ve \u0131st\u0131rap gibi ekonomik olmayan kay\u0131plar i\u00e7in paradan daha fazlas\u0131n\u0131 i\u00e7erir.<\/p>\n

S\u0131kl\u0131kla, j\u00fcriler bu durumlarda \u00f6nemli cezai tazminatlara h\u00fckmeder.<\/p>\n

Daval\u0131n\u0131n bilinen bir riski kas\u0131tl\u0131 olarak g\u00f6z ard\u0131 etti\u011fine dair a\u00e7\u0131k ve ikna edici kan\u0131tlar varsa, bu t\u00fcr ek tazminat kullan\u0131labilir.<\/p>\n

If you or a loved one has ever taken Zantac, contact Napoli Shkolnik for a \u00fccretsiz dan\u0131\u015fmanl\u0131k<\/a>.<\/p>\n

Uzmanlar\u0131m\u0131z durumunuzu de\u011ferlendirecek ve gerekirse bir kanser taramas\u0131 veya ba\u015fka bir t\u0131bbi muayene ayarlayacakt\u0131r.<\/p>","protected":false},"excerpt":{"rendered":"

Son kan\u0131tlar, pop\u00fcler mide ek\u015fimesi ilac\u0131n\u0131 artan kanser riskiyle ili\u015fkilendirir, bu nedenle FDA, Zantac'\u0131n geri \u00e7a\u011fr\u0131lmas\u0131n\u0131 talep eder. Ajans, t\u00fcm ranitidinin ma\u011faza raflar\u0131ndan derhal etkili olmas\u0131n\u0131 istiyor. \u015eu anda G\u0131da\u2026<\/p>","protected":false},"author":3,"featured_media":8117,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[776],"tags":[875,877,914,917,918,926,928,1012,816,820],"class_list":["post-8116","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmaceutical-litigation","tag-bad-drugs","tag-drug-side-effects","tag-pharmaceutical-litigation-attorney","tag-pharmaceutical-lawsuit","tag-pharmaceutical-lawyers","tag-pharmaceutical-law","tag-pharmaceutical-lawsuit-attorney","tag-zantac-injury-attorneys","tag-defective-products","tag-product-liability"],"acf":[],"page_builder_type":"gutenberg","gutenberg_data":[],"_links":{"self":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts\/8116","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/comments?post=8116"}],"version-history":[{"count":0,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/posts\/8116\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/media\/8117"}],"wp:attachment":[{"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/media?parent=8116"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/categories?post=8116"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/napolilaw.lemonadestand.org\/tr\/wp-json\/wp\/v2\/tags?post=8116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}